This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original articles
Juul, N. A. et al. KRAS(G12D) drives lepidic adenocarcinoma through stem-cell reprogramming. Nature 619, 860–867 (2023)
Kaiser, A. M. et al. p53 governs an AT1 differentiation programme in lung cancer suppression. Nature 619, 851–859 (2023)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Senft, D. AT1 cells appear centre stage. Nat Rev Cancer 23, 652 (2023). https://doi.org/10.1038/s41568-023-00618-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41568-023-00618-x